Clinical Trials Directory

Trials / Unknown

UnknownNCT03905174

Massive Implants the Next Generation

A Randomised, Single Blind Study Assessing Radiological Outcomes for Massive Segmental Femoral Replacements Using Either Porous Collar or Porous Collar With HA or Porous Collar With HA and Autologous Stem Cells

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Iva Hauptmannova · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study will review the use of massive segmental replacements in the femur, which have a porous collar with and without HA, and autologous stem cell augment. This is a randomised controlled trial.

Detailed description

The current surgical treatment of bone cancer patients and revision limb salvage requires usage of massive endoprosthetic bone implants. The incidence of aseptic loosening is a major cause of prosthesis failure in these patients, exploring ways to reduce such failures would allow extending longevity of massive implants in a relatively young population. Current published literature stipulates that osteointegration could improve longevity of massive implants. Evidence suggests that usage of osteointegrated hydroxyapatite (HA) coated collar would reduce the incidence of aseptic loosening around the cemented intramedullary stem in distal femoral bone prosthesis

Conditions

Interventions

TypeNameDescription
DEVICEcustom made devicesurgical intervention to place custom made orthopaedic device

Timeline

Start date
2018-09-20
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2019-04-05
Last updated
2022-06-07

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03905174. Inclusion in this directory is not an endorsement.